← The Wire
INKTNasdaq
MiNK Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1840229
MiNK Therapeutics develops iNKT cell therapies for GvHD, solid tumors, and multiple myeloma
$60M
Market cap
$11.91
Last close
+2.3%
1D
-2.8%
5D
14K
Volume
Price · last 39 sessions+2.7%
May 4L $10.04 · H $12.76Jun 29
74
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 23, 202610-Q10-QMay 15, 20268-KResults of OperationsMay 15, 2026DEF 14ADEF 14AApr 30, 202610-K10-KMar 31, 20268-KResults of OperationsMar 31, 20268-KCompany UpdateMar 27, 20268-KExecutive ChangeMar 19, 20268-KExecutive ChangeJan 2, 20268-KResults of OperationsDec 8, 202510-Q10-QNov 14, 20258-KExecutive ChangeSep 29, 2025424B5424B5Aug 22, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KMaterial AgreementJul 15, 2025424B5424B5Jul 15, 20258-KCompany UpdateJul 14, 20258-KShareholder VoteJun 18, 202510-Q10-QMay 15, 20258-KResults of OperationsMay 15, 2025DEF 14ADEF 14AApr 30, 202510-K10-KMar 18, 20258-KResults of OperationsMar 18, 20258-KBylaw Amendment · Shareholder VoteJan 21, 2025DEF 14ADEF14ADec 20, 202410-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KExecutive ChangeOct 31, 20248-KExecutive ChangeOct 18, 20248-KDelisting NoticeSep 13, 20248-KDelisting NoticeAug 30, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KShareholder VoteJun 17, 2024SC 13GGKCC LLC SCHEDULE 13GMay 22, 20248-KMaterial Agreement · Equity IssuanceMay 16, 20248-KResults of OperationsMay 14, 202410-Q10-QMay 14, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 21, 20248-KResults of OperationsMar 21, 20248-KDelisting NoticeFeb 29, 2024SC 13DSC 13DFeb 14, 20248-KMaterial Agreement · New Debt / ObligationFeb 14, 202410-Q10-QNov 14, 20238-KResults of OperationsNov 9, 20238-KExecutive ChangeOct 17, 20238-KResults of OperationsAug 10, 202310-Q10-QAug 10, 20238-KShareholder VoteJun 20, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEF 14ADEF 14AMay 1, 202310-K10-KMar 24, 20238-KResults of OperationsMar 21, 20238-KResults of OperationsNov 3, 202210-Q10-QNov 3, 202210-Q10-QAug 15, 20228-KResults of OperationsAug 9, 20228-KMaterial AgreementAug 5, 20228-KExecutive Change · Shareholder VoteJun 14, 202210-Q10-QMay 13, 20228-KResults of OperationsMay 10, 2022DEF 14ADEF 14AApr 29, 202210-K10-KMar 18, 20228-KExecutive ChangeMar 8, 2022SC 13GSC 13GFeb 14, 20228-KExecutive ChangeJan 6, 202210-Q10-QNov 29, 20218-KSecurity-Holder Rights · Bylaw AmendmentOct 20, 2021424B4424B4Oct 15, 2021S-1/AS-1/AOct 12, 2021S-1S-1Sep 14, 2021
Insider Activity
In the 90 days to Mar 10, 2026: 1 sold $27K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 500 | $15.57 | $8K |
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 500 | $15.30 | $8K |
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 300 | $15.28 | $5K |
| Mar 9, 2026 | Ryan BarbaraDirector | Sell | 200 | $10.17 | $2K |
| Mar 2, 2026 | Ryan BarbaraDirector | Sell | 100 | $10.83 | $1K |
| Feb 27, 2026 | Ryan BarbaraDirector | Sell | 400 | $10.86 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance